TMEM70 deficiency: long-term outcome of 48 patients

. 2015 May ; 38 (3) : 417-26. [epub] 20141018

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid25326274

OBJECTIVES: TMEM70 deficiency is the most common nuclear-encoded defect affecting the ATP synthase. In this multicentre retrospective study we characterise the natural history of the disease, treatment and outcome in 48 patients with mutations in TMEM70. Eleven centers from eight European countries, Turkey and Israel participated. RESULTS: All 27 Roma and eight non-Roma patients were homozygous for the common mutation c.317-2A > G. Five patients were compound heterozygotes for the common mutation and mutations c.470 T > A, c.628A > C, c.118_119insGT or c.251delC. Six Arab Muslims and two Turkish patients were homozygous for mutations c.238C > T, c.316 + 1G > T, c.336 T > A, c.578_579delCA, c.535C > T, c.359delC. Age of onset was neonatal in 41 patients, infantile in six cases and two years in one child. The most frequent symptoms at onset were poor feeding, hypotonia, lethargy, respiratory and heart failure, accompanied by lactic acidosis, 3-methylglutaconic aciduria and hyperammonaemia. Symptoms further included: developmental delay (98%), hypotonia (95%), faltering growth (94%), short stature (89%), non-progressive cardiomyopathy (89%), microcephaly (71%), facial dysmorphism (66%), hypospadias (50% of the males), persistent pulmonary hypertension of the newborn (22%) and Wolff-Parkinson-White syndrome (13%). One or more acute metabolic crises occurred in 24 surviving children, frequently followed by developmental regression. Hyperammonaemic episodes responded well to infusion with glucose and lipid emulsion, and ammonia scavengers or haemodiafiltration. Ten-year survival was 63%, importantly for prognostication, no child died after the age of five years. CONCLUSION: TMEM70 deficiency is a panethnic, multisystemic disease with variable outcome depending mainly on adequate management of hyperammonaemic crises in the neonatal period and early childhood.

Erratum v

PubMed   Morava-Kozicz, Eva [corrected to Morava, Eva]

Zobrazit více v PubMed

Mol Genet Metab. 2014 Mar;111(3):353-359 PubMed

Neurogenetics. 2012 Nov;13(4):375-86 PubMed

Mitochondrion. 2011 Nov;11(6):954-63 PubMed

Nat Genet. 2006 May;38(5):576-82 PubMed

Mitochondrion. 2011 Jan;11(1):191-9 PubMed

Physiol Res. 2014;63(Suppl 1):S57-71 PubMed

Brain. 2009 Jan;132(Pt 1):136-46 PubMed

J Inherit Metab Dis. 2013 Nov;36(6):913-21 PubMed

J Inherit Metab Dis. 2012 Sep;35(5):749-59 PubMed

Hum Mol Genet. 1999 Oct;8(11):1967-74 PubMed

Nat Genet. 2008 Nov;40(11):1288-90 PubMed

Eur J Pediatr. 2008 Aug;167(8):941-4 PubMed

Gene. 2013 Feb 15;515(1):197-9 PubMed

J Pediatr Endocrinol Metab. 2013;26(1-2):151-4 PubMed

Pediatrics. 2006 Aug;118(2):e337-46 PubMed

Biochim Biophys Acta. 2011 Jan;1807(1):144-9 PubMed

Arch Dis Child. 2010 Apr;95(4):296-301 PubMed

Am J Hum Genet. 2012 Feb 10;90(2):314-20 PubMed

Neuromuscul Disord. 2006 Dec;16(12):821-9 PubMed

Mitochondrion. 2014 Mar;15:1-9 PubMed

Mol Genet Metab. 2010 Oct-Nov;101(2-3):282-5 PubMed

Clin Genet. 2011 Sep;80(3):297-300 PubMed

J Med Genet. 2011 Mar;48(3):177-82 PubMed

JAMA. 1967 Jan 9;199(2):121-2 PubMed

J Inherit Metab Dis. 2006 Oct;29(5):684 PubMed

Pediatr Res. 2012 Oct;72(4):432-7 PubMed

Orphanet J Rare Dis. 2012 May 29;7:32 PubMed

JIMD Rep. 2015;15:71-8 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace